Viewing Study NCT04360005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-03-11 @ 2:50 PM
Study NCT ID: NCT04360005
Status: AVAILABLE
Last Update Posted: 2025-12-05
First Post: 2020-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Managed Access Programs for ABL001, Asciminib
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia in Chronic Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic myeloid leukemia View
None CML View
None CML-CP View
None Asciminib View
None ABL001 View